Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

Clinical trial NCT01398462 · COMPLETED

Trial details

NCT number: NCT01398462
Sponsor: JW Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome Myelofibrosis

Start date: 2011-07-01
Primary completion: 2015-12-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.